COVID-19: What Does It Mean For My Patients With Diabetes?

This discussion will address type 1 and type 2 diabetes in children and adults.

Learning Objectives

  1. What should persons with diabetes know about COVID-19 and diabetes?
  2. How can you prepare?
  3. Sick day management during COVID-19 pandemic
  4. How are healthcare providers adapting their diabetes care during the COVID-19 outbreak?
  5. What should I do if I think I have COVID-19?
  6. Reviewing reliable sources of information about COVID-19

Speaker

Mark Clements, MD, PhD
Chief Medical Officer

Leading endocrinologist recognized as an expert in diabetes data analytics with broad patient care and clinical research experience. Dr. Clements joined the senior management team of Glooko, recently, having served on its medical advisory board since it was formed in 2015 to provide expertise to the organization in the areas of clinical studies and diabetes analytics.

Dr. Clements earned his Bachelor of Science degree in Biology and Chemistry (1993) at Butler University, Indianapolis, IN. Following, Dr. Clements earned his Medical Degree (2003) and PhD in Developmental Neuroscience (2003) at Washington University, St. Louis, MO. His previous training in the Medical Scientist Training Program at Washington University School of Medicine provided a strong foundation in basic science research. Dr Clements trained as a clinical researcher at Children’s Mercy Hospital, where he has applied his skills to clinical trials of new diabetes treatments, clinical trials of treatments designed to prevent type 1 diabetes, intervention development research and risk prediction research in type 1 diabetes. He has a particular interest in the application of new technologies that can improve blood glucose data sharing and communication between patient and provider, so that better diabetes control can be achieved.